<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260511069351N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-04</date_registration>
      <primary_sponsor>Gerash University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of aromatherapy with lavender and rose essential oil on pain score, anxiety score and physiological indicators in patients undergoing coronary catheterization through the radial artery</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of aromatherapy with lavender and rose essential oil on pain score, anxiety score and physiological indicators in patients undergoing coronary catheterization through the radial artery: A Randomized Controlled  Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-07-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>123</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/90055</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Block Randomization Method

The method will be accessible. Block randomization will be performed to allocate 123 patients into three groups (41 individuals per group: A, B, C). This method ensures group balance and eliminates allocation prediction.

Calculation of block size and number of blocks
Block size: 6 individuals (2 per group; small block; multiplier of 3 for complete balance)
Number of blocks: total sample size (123) divided by block size (6) equals 20 full blocks (120 individuals) + 1 incomplete block (2 individuals) (each block includes balanced random combinations such as AAB, BCC, or ABC).

Blocks will be generated using the R software package (blockrand) and placed in sealed envelopes in Excel. The allocation will be performed independently and blindly. Block selection for intervention will be random. To prevent interference from routine effects, weekly interventions will be carried out. For example, block (ABC) includes three interventions: A intervention and C control in the first week, B intervention in the second week, and C group in the third week. After the third week, the second block will be randomly selected, following the same procedure until the sample size reaches 41 individuals per block.</study_design>
      <phase>N/A</phase>
      <hc_freetext>the effect of aromatherapy with lavender and rose essential oil on pain score, anxiety score and physiological indicators in patients undergoing coronary catheterization through the radial artery.</hc_freetext>
      <i_freetext>Intervention 1: The first Intervention group: inhaled 5 drops of pure lavender essential oil produced by Barij Essence Pharmaceutical Company, Kashan, for 20 minutes. Intervention 2: The second Intervention group: inhaled 5 drops of pure rose essential oil produced by Barij Essence Pharmaceutical Company, Kashan, for 20 minutes. Intervention 3: Control group: inhaled 5 drops of distilled water for 20 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No further information is available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyyedeh Boshra Sheikhahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sayeh Complex, Hoveyzeh St, Jam-e Jam St</address>
        <city>Sanandaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6617963753</zip>
        <telephone>+98 87 3362 9291</telephone>
        <email>boshra.sh1377@gmail.com</email>
        <affiliation>Gerash University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hajar Haghshenas</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Gerash University of Medical Scienes, Daneshjoo Blvd</address>
        <city>Gerash</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>74417586666</zip>
        <telephone>+98 71 5244 8101</telephone>
        <email>haghshenah@gmail.com</email>
        <affiliation>Gerash University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Candidate selection via coronary catheterization through the radial artery
Filling out the informed consent form voluntarily
Age over 18 years
Ability to read and write (literacy)
Awareness of the time, place, and person</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first Intervention group: inhaled 5 drops of pure lavender essential oil produced by Barij Essence Pharmaceutical Company, Kashan, for 20 minutes</i_keyword>
      <i_keyword>The second Intervention group: inhaled 5 drops of pure rose essential oil produced by Barij Essence Pharmaceutical Company, Kashan, for 20 minutes</i_keyword>
      <i_keyword>Control group: inhaled 5 drops of distilled water for 20 minutes</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score. Timepoint: Before, during, 10, 20, 30 minutes after arterial sheath removal. Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Anxiety score. Timepoint: Before the intervention, before and 30 minutes after arterial sheath removal. Method of measurement: Spielberger State Anxiety Inventory.</prim_outcome>
      <prim_outcome>Physiological indicators (systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate, respiratory rate and arterial blood oxygen saturation percentage). Timepoint: Before, during, 10, 20, 30 minutes after arterial sheath removal. Method of measurement: Pouyandegan Rah Saadat company's Vital signs monitoring device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Gerash University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-04-07</approval_date>
        <contact_name>Ethics committee of Gerash University of Medical Sciences</contact_name>
        <contact_address>Imam Hossein (AS) Blvd, Daneshjoo Blvd, Gerash  University of Medical Sciences Gerash Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
